NIH Human Fetal Tissue Research Ethics Advisory Board-FY2020
 Office of Science Policy
 National Institutes of Health
 6705 Rockledge Drive, Suite 750
 Bethesda, MD 20892
Dear Members of the NIH Human Fetal Tissue Research Ethics Advisory Board,
On behalf of the scientific, medical, and patient communities dedicated to advancing human health, we write to express our collective, strong support for the continued use of human fetal tissue in life-saving biomedical research. As you evaluate the ethics of research proposals necessitating the use of human fetal tissue, we urge you to consider its potential to advance our understanding of human biology and the development of new treatments that will reduce suffering from human diseases.
Research using human fetal tissue has been essential for scientific and medical advances that have saved millions of lives, and it remains a crucial resource for biomedical research. Fetal tissue has unique and valuable properties that often cannot be replaced by other cell types. Cells from fetal tissue are more flexible and less specialized than cells from adult tissue and can be more readily grown in culture. This is part of the reason why fetal tissue is used for the generation of vaccines and for studying infectious diseases like Zika, HIV, and other viruses. It is also the reason why human fetal tissue is used to develop and validate model systems to study the progression of diseases and test new therapeutics.
While some have argued that advances in recent years have reduced the need for fetal tissue in certain areas of research, fetal tissue remains the gold standard for evaluating the accuracy of models of human fetal development. Fetal tissue also remains an essential resource for studying complex interactions between cells. Fetal cell lines are not a substitute for fetal tissue, because they are limited to a small number of cell types and are inadequate for studying complex interactions between cells. Similarly, organoids and stem cell model systems are simplistic models that only mimic certain aspects of human development. Finally, tissue from spontaneous abortions is not a reliable substitute for tissue from induced abortions, because they often result from genetic defects, developmental abnormalities, or other conditions that undermine the availability and usefulness of the tissue.
The long-standing existing review process for fetal tissue research ensures that research using fetal tissue is scientifically meritorious, legal, and ethically sound. The legal framework for this research prohibits people from profiting from acquiring, receiving, or transferring fetal tissue for research. Each research proposal has already been favorably evaluated by subject matter experts on NIH study sections for scientific and technical merit, including significance, innovation, and approach. As the nation continues to respond to the coronavirus pandemic, we urge you to consider the potential of fetal tissue research to accelerate the development of new vaccines and viral therapies, not only for coronavirus but also for other incurable viral pathogens such as Zika and HIV. Fetal tissue research has the potential to accelerate the end to the pandemic, reduce human suffering, and enable the U.S. to better respond to future public health threats.
As organizations representing scientists, clinicians, and patients driven by a desire to improve the health and well-being of all, we urge you to consider the scientific and medical significance of fetal tissue research and its crucial role in the development of new therapies. Thank you for considering our views.
Sincerely,
Academic Pediatric Association
 AIDS Foundation Chicago
 AIDS Treatment Activists Coalition (ATAC)
 Alliance for Aging Research
 American Academy of HIV Medicine
 American Academy of Pediatrics
 American Association for Anatomy
 American Association for the Advancement of Science
 American Association of Colleges of Pharmacy
 American Association of Immunologists
 American Brain Coalition
 American Institute of Biological Sciences
 American Pediatric Society
 American Physiological Society
 American Society for Cell Biology
 American Society for Investigative Pathology
 American Society for Reproductive Medicine (ASRM)
 American Society of Hematology
 American Society of Human Genetics
 American Thoracic Society
 Association of American Medical Colleges
 Association of American Universities
 Association of Independent Research Institutes
 Association of Medical School Pediatric Department Chairs
 Association of Public & Land-Grant Universities
 AVAC
 Axis Advocacy
 Boston University
 Coalition for the Life Sciences
 Columbia University Irving Medical Center
 Council on Governmental Relations
 Duke University
 Endocrine Society
 Federation of American Societies for Experimental Biology
 Fred Hutchinson Cancer Research Center
 GLMA: Health Professionals Advancing LGBTQ Equality
 Global Healthy Living Foundation
 Harvard University
 HIV Medicine Association
 HIV+Aging Research Project-Palm Springs
 Infectious Diseases Society of America
 International Foundation for Autoimmune & Autoinflammatory Arthritis (AiArthritis)
 International Society for Stem Cell Research
 ISCT, International Society for Cell & Gene Therapy
 Jacobs Institute of Women’s Health
 Johns Hopkins University
 Massachusetts General Hospital
 Medical College of WI
 Medical Students for Choice
 Michigan State University
 National Alliance for Eye and Vision Research
 National Alliance on Mental Illness
 National Coalition for LGBT Health
 National Women’s Health Network
 Nebraska Coalition for Lifesaving Research
 NYU Langone Health
 Pediatric Policy Council
 Princeton University
 Research!America
 Rutgers, The State University of New Jersey
 Society for Maternal-Fetal Medicine
 Society for Neuroscience
 Society for Pediatric Research
 Society of Family Planning
 Society of Toxicology
 Stanford University
 Stony Brook University
 Texans for Cures
 The Michael J. Fox Foundation for Parkinson’s Research
 The New York Stem Cell Foundation
 The State University of New York
 Treatment Action Group
 Tuberous Sclerosis Alliance
 UCLA
 Union of Concerned Scientists
 University at Buffalo
 University of California San Diego
 University of California System
 University of California, Irvine
 University of California, San Francisco
 University of Illinois College of Medicine
 University of Massachusetts Medical School
 University of Michigan
 University of Oregon
 University of Pittsburgh
 University of Rochester
 University of Washington
 University of Wisconsin-Madison School of Medicine and Public Health
 Weill Cornell Medicine
 Yale University